Aleman Tomas S, Roman Alejandro J, Uyhazi Katherine E, Jiang Yu You, Bedoukian Emma C, Sumaroka Alexander, Wu Vivian, Swider Malgorzata, Viarbitskaya Iryna, Russell Robert C, Shagena Elizabeth O, Santos Arlene J, Serrano Leona W, Parchinski Kelsey M, Kim Rebecca J, Weber Mariejel L, Garafalo Alexandra V, Thompson Dorothy A, Maguire Albert M, Bennett Jean, Scoles Drew H, O'Neil Erin C, Morgan Jessica I W, Cideciyan Artur V
Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Division of Ophthalmology and The Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):30. doi: 10.1167/iovs.65.14.30.
The purpose of this study was to determine the natural history of the photoreceptor disease in a large group of pediatric patients with RHD12-associated Leber congenital amaurosis (RDH12-LCA), to estimate the changes expected over the duration of a clinical trial, and to define the relationship between the photoreceptor loss and visual dysfunction.
Forty-six patients representing 36 families were included. The great majority of patients were under the age of 18 years. Patients underwent complete ophthalmic examinations and imaging with various modalities including adaptive optics scanning laser ophthalmoscopy. Visual function was assessed with static and kinetic perimetry, and full-field stimulus test (FST) under dark- and light-adapted conditions.
Patients had a severe and early onset retinal degeneration (EORD). Visual acuity losses showed a progression rate of 0.04 logMAR per year. A small foveal island could be retained but showed degeneration over time. Foveal cone sensitivity losses were predictable by the loss of photoreceptors. Peripapillary retina could be retained with no significant progression detectable. Peripapillary rod sensitivity was substantially less than expected from photoreceptor structure pointing to a large improvement potential. FST sensitivities were reliably recordable in pediatric patients and showed a small but significant improvement with age. Locally and globally, loss of rod sensitivity tended to be larger than loss of cone sensitivity.
Foveal cones of RDH12-LCA should be targeted with treatments aimed to slow progression, whereas peripapillary rod photoreceptors should be targeted with treatments aimed to improve night vision. Pediatric FST testing may be complicated by age-related maturation of decision making regarding threshold criteria.
本研究的目的是确定一大组患有与RHD12相关的莱伯先天性黑矇(RDH12-LCA)的儿科患者中光感受器疾病的自然史,估计临床试验期间预期的变化,并确定光感受器丧失与视觉功能障碍之间的关系。
纳入了代表36个家庭的46例患者。绝大多数患者年龄在18岁以下。患者接受了全面的眼科检查和包括自适应光学扫描激光检眼镜在内的各种成像检查。通过静态和动态视野检查以及在暗适应和明适应条件下的全视野刺激试验(FST)评估视觉功能。
患者患有严重的早发性视网膜变性(EORD)。视力丧失显示每年进展率为0.04 logMAR。可以保留一个小的中央凹岛,但随时间显示出变性。中央凹视锥细胞敏感性丧失可通过光感受器丧失来预测。视乳头周围视网膜可以保留,未检测到明显进展。视乳头周围视杆细胞敏感性明显低于光感受器结构预期的值,表明有很大的改善潜力。FST敏感性在儿科患者中可以可靠地记录,并且随年龄增长有小但显著的改善。在局部和整体上,视杆细胞敏感性丧失往往大于视锥细胞敏感性丧失。
对于RDH12-LCA的治疗,应针对中央凹视锥细胞以减缓疾病进展,而针对视乳头周围视杆光感受器的治疗应旨在改善夜视力。儿科FST测试可能因与年龄相关的阈值标准决策成熟度而变得复杂。